---
layout: default
title: 9.1 Pharmaceutical
parent: 9. Case Studies per Industry
nav_order: 1
permalink: /case_studies_industry_pharmaceutical.html
---

## Table of contents
{: .no_toc .text-delta }

1. TOC
{:toc}

# Design of Experiments

#### Opthalmic Drug Delivery System ([`Fractional Factorial`](https://www.docs.isalos.novamechanics.com//screening.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2013_Achouri\2013_Achouri_NemrodW_2.iap)
* [Report](files\DoE\Pharmaceuticals\2013_Achouri\2013_Achouri.pdf)

#### Formulation of extended release beads ([`Box Behnken`](https://www.docs.isalos.novamechanics.com///response-surface.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2014_Mujtaba\2014_Mujtaba_DesignExpert.iap)
* [Report](files\DoE\Pharmaceuticals\2014_Mujtaba\2014_Mujtaba.pdf)

#### Development of microsponge based gel ([`Box Behnken`](https://www.docs.isalos.novamechanics.com///response-surface.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2015_Kumar\2015_Kumar_DesignExpert 8.0.7.1.iap)
* [Report](files\DoE\Pharmaceuticals\2015_Kumar\2015_Kumar.pdf)

#### Formulation of a bi-dependent drug delivery system ([`Box Behnken`](https://www.docs.isalos.novamechanics.com///response-surface.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2016_Malladi\2016_Malladi_DesignExpert 8.0.1.iap)
* [Report](files\DoE\Pharmaceuticals\2016_Malladi\2016_Malladi.pdf)

#### Iontophoretic Tacrine Hydrochloride Delivery ([`Central Composite - CCF`](https://www.docs.isalos.novamechanics.com///response-surface.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2016_Patel\2016_Patel_DesignExpert.iap)
* [Report](files\DoE\Pharmaceuticals\2016_Patel\2016_Patel.pdf)

#### Development of pellets for oral lysozyme delivery ([`Full Factorial`](https://www.docs.isalos.novamechanics.com///factorial.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2016_Sovany\2016_Sovany_Statistica.iap)
* [Report](files\DoE\Pharmaceuticals\2016_Sovany\2016_Sovany.pdf)

#### Development of nanostructured lipid carriers ([`Full Factorial`](https://www.docs.isalos.novamechanics.com///factorial.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2017_Kovacs\2017_Kovacs_LeanQbD_Statistica.iap)
* [Report](files\DoE\Pharmaceuticals\2017_Kovacs\2017_Kovacs.pdf)

#### Development of silymarin nanoemulsion ([`Box Behnken`](https://www.docs.isalos.novamechanics.com///response-surface.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2017_Nagi\2017_Nagi_DesignExpert 9.0.4.1.iap)
* [Report](files\DoE\Pharmaceuticals\2017_Nagi\2017_Nagi.pdf)

#### Gelling microemulsion of Lorazepam ([`Full Factorial`](https://www.docs.isalos.novamechanics.com///factorial.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2017_Shah\2017_Shah_DesignExpert 7.0.2.iap)
* [Report](files\DoE\Pharmaceuticals\2017_Shah\2017_Shah.pdf)

#### Polymeric micelles for cancer treatment ([`Full Factorial`](https://www.docs.isalos.novamechanics.com///factorial.html))
{: .no_toc }
* [Isalos workflow](files\DoE\Pharmaceuticals\2017_Valenzuela-Oses\2017_Valenzuela-Oses_Minitab_GraphPad.iap)
* [Report](files\DoE\Pharmaceuticals\2017_Valenzuela-Oses\2017_Valenzuela-Oses.pdf)


